Watch this Space!

We will be announcing more exciting presentations soon...

Conference Opening Times:

 

14 March: 08:00 - 19:30  |  15 March: 08:00 - 17:45

 

Session Titles

Bioinformatic Challenges in Microbiome Analyses
Regulatory Affairs
Identifying Biomarkers

Bioinformatic Challenges in Microbiome Analyses

Regulatory Affairs

The Latest Science

Identifying Biomarkers

Innovation Showcase
Classifying the Microbiota
Skin: A New Target for Microbiota Interventions

Innovation Showcase & Young Investigators Award

Developing Live Biotherapeutic Products

Skin: A New Target for Microbiota Interventions

Taxonomic Thunderclouds

Conference Programme

 

DAY 1

DAY 2

 

08:00 - 08:40am

Registration Sponsored by Probiotical

 

 

08:45 - 09:15am

Key Note: Live Biotherapeutics; Enhancing Health Through Modulating the Human Microbiome

Paul Cotter

 

Taxonomic Thunderclouds

 

09:15 - 09:45am

Untangling the Evolutionary Development of the Genus Bifidobacterium by Comparative Genomics

Marco Ventura

 

09:45 - 10:15am

Deciphering the Diversity of Genus Lactobacillus:

A Taxonomic Tale

Giovanna Felis

 

10:15 - 10:30am

Therapeutic Potential of Probiotics for Mood: New

Evidence from a Double-blind, Placebo Controlled Study

Marco Pane

 

Regulatory Affairs Chaired by Colette Shortt

 

11:15 - 11:45am

The PRI: An Innovative Approach in Absence of Clear Regulatory Framework at the EU Level

Magali Cordaillat-Simmons

 

11:45am - 12:15pm

Nagoya Protocol: Legal Framework and Practical Consequences

Katia Martin-Lentz

 

12:15 - 13:00pm

Interactive Session: Internationalisation of Regulatory Issues

for Pharmabiotics: What Needs to be Done?

Moderator: Sin-Hyeog Im

Participants: Colette Shortt, Magali Cordaillat-Simmons

 

 

Skin: A New Target for Microbiota Interventions

Chaired by Bernard Pietzold

 

14:00 - 14:30pm

Skin Microbiota: Interest and Management

Richard Martin

 

14:30am - 15:00pm

Investigating and Understanding the Role of the Skin Microbiota in Skin Disorders

Holger Brüggemann

 

15:00 - 15:30pm

'Bugs as Drugs' for the Skin: Novel Microbiome-based Strategies for Skin Diseases

Travis Witfil

 

The Latest Science

 

16:45 - 17:15pm

How to Develop Probiotics as Immune-modulatory Pharmabiotics

Sin-Hyeog Im

 

17:15 - 17:45pm

Title & Speaker to be confirmed

 

17:45 - 18:00pm

Biofortis Presentation and Introduction of Young Investigator Awards Finalists

 

18:00 - 18:30pm

Young Investigator Awards Finalists' Presentations

 

Bioinformatic Challenges in Microbiome Analyses

by Bruno Pot

 

16:15 - 16:45pm

How Can You Trust your Analysis Results from Targeted Metagenomics Studies?

Ségolène Caboche

 

16:45 - 17:15pm

The Challenges in Performing Metagenomic Studies to Understand the Role of Gut Microbiome in Diseases

Manimozhiyan Arumugam

 

Innovation Showcase Chaired by Richard Ellis

 

14:30 - 15:00pm

Pioneering Microbiome Innovations

David Berry

 

15:00 - 15:05pm

Start-Up 1

 

15:05 - 15:10pm

Start-Up 2

 

15:10 - 15:15pm

Start-Up 3

 

15:15 - 15:20pm

Start-Up 4

 

15:20 - 15:30pm

Start-Up 5

 

Identifying Biomarkers Chaired by Adrien Nivoliez

 

11:15 - 11:45am

Biomarkers in Diabetes

(Title & Speaker TBC)

 

11:45am - 12:15pm

Biomarkers in Osteoarthritis: Where are we?

Where are we Going?

Yves Henrotin

 

12:15 - 12:45pm

Emerging Biomarkers in Oncology Related to Microbiome Disruption. Where are we Now and Where do we Need to go?

Jack Gilbert & John Slattery

 

Developing Live Biotherapeutic Products

 

09:00 - 09:30am

Personalized Pharmabiotics for Correction of Nosology and Individual Specific Microbiota and Immune Response

Nadya Boyko

 

09:30 - 10:00am

Ultra-high Resolution Microbiomics

Pernille Myers

 

10:00 - 10:30am

A Systematic Review with Meta-analysis of a Pharmabiotic Composition for the Management of Ulcerative Colitis Remission in a Chinese Population

Thomas Tompkins

 

09:00 - 08:40am

Key Note II: The Microbiome: What Pharma Wants, What Pharma Thinks?

Marie Lindner

 

08:40 - 08:45am

Welcome Address by Bruno Pot

 

10:30 - 11:15am

Coffee Break Sponsored by Zymo Research

 

 

13:00 - 14:00pm

Lunch Sponsored by Winclove

 

 

15:45 - 16:45pm

Coffee Break Sponsored by Zymo Research

 

 

15:30 - 16:15pm

Coffee Break

 

 

10:30 - 11:15am

Coffee Sponsored by Lallemand

 

 

08:00 - 08:30am

Registration Sponsored by Probiotical

 

 

12:45 - 13:00pm

From Dysbiosis to Cancer: Microbiome Research in

Oncology and its Impact for Health and Therapy

Adolf Heschl

 

15:30 - 15:45pm

Standardising Microbiomics - Removing Bias

in Collection, Purification and Analyses

Sarah Hemmasi

 

18:15 - 19:15pm

YIA Awards Ceremony & Cocktail Reception

Sponsored by PRI

 

 

17:15 - 17:45pm

Panel Discussion: How to Overcome the Difficulties

Relating to the Inter-Analysis Variability

 

 

13:30 - 14:30pm

Lunch Sponsored by Winclove

 

Speakers & Chairs

David Berry

General Partner

Flagship Pioneering

Manimozhiyan Arumugam Associate Professor

Novo Nordisk Foundation

Travis Whitfill

Co-Founder & CSO

Azitra Inc

Sin-Hyeog Im

Professor

IBS/POSTECH

John Slattery

Director of Research and Innovation

Aces Health Inc.

Marie Lindner

Global Head, Strategic Partnerships Team

Novartis

Yolanda Sanz

Professor

 

IATA-CSIC

Holger Brüggemann Associate Professor

AARHUS University

Adrien Nivoliez

CEO

Biose Industrie

Giovanna Felis

Associate Professor University of Verona

Paul Cotter

Prinicpal Investigator

APC Microbiome Institute

Yves Henrotin

Professor

University of Liège

Pernille Myers

Bioinformatics Specialist Clinical Microbiomics

Magali Cordaillat-Simmons Executive Scientist

PRI

Bruno Pot

President

PRI

Sarah Hemmasi

Research Associate

Zymo Research

Katia Merten-Lentz

Partner

Keller and Heckman LLP

Marco Ventura

Professor

University of Parma

Colette Shortt

Johnson & Johnson

Richard Martin

CEO

Mercurialis Biotech

Ségolène Caboche

Bioinformatics Researcher

Université de Lille

Nadiya Boyko

Professor

Uzhhorod National University

Stephanie Ferreira

Innovation Manager GenoScreen

Richard Ellis

Business Development

PRI

Marco Pane

Product Specialist

Probioitcal

Adolf Heschl

Lecturer

University of Graz

Call for Abstracts

Pharmabiotics 2018 focuses on the science and business of new research and technologies for treating diseases and sustaining health via the Human Microbiota.

 

If you are an expert in the field, either from Academia or Industry and have research to present (verbal or poster), we would like to hear from you!

 

Please complete the form on the right, following the specified guidelines:

 

 

Abstract Submission Guidelines

 

General Criteria

 

Only abstracts on recent original research related to the influence of the microbiota, as well as the analytical tools, therapeutic potential, mechanisms of action, pre-clinical and clinical efficacy in the treatment or prevention of pathologies will be accepted.

 

 

Abstract Format

 

Language English

 

Length Up to 300 words are accepted. Abstracts cannot include tables or figures.

 

Only standardized abbreviations will be allowed. Any abbreviation should be explained in brackets the first time it appears in the text.

 

Selection will be carried out on the basis of overall quality of the abstract and special interest by the scientific committee. Abstract acceptance or rejection will be notified by e-mail along with presentation criteria and other details.

 

The scientific committee reserves the rights to reject proposals that are beyond the scope of the conference.

 

Submissions imply the intent of at least one author to register, attend the conference and present the study. The author has to be registered before January 31st 2018.

 

 

 

Fill out my online form.
HTML Forms powered by Wufoo.

Sponsors